Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    olanzapina

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LYBALVI Long-Term Data on Schizophrenia Published in JCP
    LYBALVI Long-Term Data on Schizophrenia Published in JCP

    14 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260414639785/en/Findings-From-Long-Term-Analysis-of-the-Effects-of-LYBALVI-olanzapine-and-samidorphan-on-Negative-Symptoms-of-Schizophrenia-Published-in-The-Journal-of-Clinical-Psychiatry

    BUSINESSWIRE
    14 Apr 2026
    Share Share
    Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety
    Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262573/32445/en/Minerva-Neurosciences-Presents-Data-from-its-Open-label-Safety-Trial-Evaluating-Roluperidone-Co-administered-with-Olanzapine-at-SIRS-2026.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Anthea Pharma’s Generics Olanzapine Receives Approval in US
    Anthea Pharma’s Generics Olanzapine Receives Approval in US

    05 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220323

    FDA
    05 Mar 2026
    Share Share
    Omnivium Pharms’ Generics Olanzapine Receives Approval in US
    Omnivium Pharms’ Generics Olanzapine Receives Approval in US

    23 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219048

    FDA
    23 Jan 2026
    Share Share
    Teva Submits FDA Application For Olanzapine Injectable
    Teva Submits FDA Application For Olanzapine Injectable

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202267/0/en/Teva-Pharmaceuticals-Submits-New-Drug-Application-to-FDA-for-Olanzapine-Extended-Release-Injectable-Suspension-TEV-749-for-the-Once-Monthly-Treatment-of-Schizophrenia-in-Adults.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Teva Reveals Promising SOLARIS Results for Olanzapine LAI
    Teva Reveals Promising SOLARIS Results for Olanzapine LAI

    23 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/teva-unveils-promising-solaris-resultsfor-olanzapine-lai-17853

    INDPHARMAPOST
    23 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.